Skip to content
HowShorted

Immunome, Inc. short interest in 2026

In 2026, Immunome, Inc.'s disclosed short interest ran from 16.70% of shares outstanding on 15 Jan 2026 to 14.30% on 15 Sep 2026, a change of -2.40 percentage points. The year's high was 17.49% on 13 Feb 2026 and its low 13.77% on 31 Aug 2026, averaging 15.83% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.64 days on 27 Feb 2026. Full history: Immunome, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Immunome, Inc. in 2026

2026 in figures

Start of year
16.70% (15 Jan 2026)
End of year
14.30% (15 Sep 2026)
Change
-2.40 pp
High
17.49% (13 Feb 2026)
Low
13.77% (31 Aug 2026)
Average
15.83%
Highest days to cover
23.64 (27 Feb 2026)
SEC filings marked
6

Every report in 2026

Immunome, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202616.70%6.25
30 Jan 202617.19%9.05
13 Feb 202617.49%12.32
27 Feb 202615.81%23.64
13 Mar 202615.81%14.7410-K filed, results (8-K)
31 Mar 202616.75%10.57
15 Apr 202616.44%16.64
30 Apr 202616.49%22.64
15 May 202615.58%20.0610-Q filed, results (8-K)
29 May 202614.91%14.16
15 Jun 202616.04%12.93
30 Jun 202615.35%8.12
15 Jul 202615.24%10.54
31 Jul 202615.89%22.98
14 Aug 202615.31%14.9310-Q filed, results (8-K)
31 Aug 202613.77%12.64
15 Sep 202614.30%20.63

See also: Immunome, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.